Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Andreas Ranft

Showing results (61-70 of 84) with videos related to

Pageof 9
Sort By:
European Journal of Cancer Care|June 23, 2020
Fertility education for adolescent cancer patients: Gaps in current clinical practice in EuropeElisabeth Korte, Ralph Schilling, Magdalena Balcerek, et al.
Advances in Radiation Oncology|June 19, 2023
Effect of Radiotherapy Dose on Outcome in Nonmetastatic Ewing SarcomaJosephine Kersting, Andreas Ranft, Vivek Bhadri, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|March 24, 2010
Impact of EWS-ETS fusion type on disease progression in Ewing's sarcoma/peripheral primitive neuroectodermal tumor: prospective results from the cooperative Euro-E.W.I.N.G. 99 trialMarie-Cecile Le Deley, Olivier Delattre, Karl-Ludwig Schaefer, et al.
European Journal of Cancer (Oxford, England : 1990)|August 18, 2023
Association between local treatment modalities and event-free survival, overall survival, and local recurrence in patients with localised Ewing Sarcoma. Report from the Ewing 2008 trialPhilip Heesen, Andreas Ranft, Vivek Bhadri, et al.
European Journal of Cancer (Oxford, England : 1990)|May 30, 2026
Treatment effect heterogeneity of radiotherapy in localized Ewing sarcoma: A secondary analysis of the EURO-E.W.I.N.G. 99 and Ewing 2008 trialPhilip Heesen, Stefan Feuerriegel, Olga Ciobanu-Caraus, et al.
European Journal of Cancer (Oxford, England : 1990)|July 20, 2024
Impact of age on safety of Busulfan-Melphalan followed by autologous hematopoietic stem-cell transplantation versus standard chemotherapy in the patients of the EURO-E.W.I.N.G. 99 and Ewing 2008 clinical trialsXavier Choderlos de Laclos, Séverine Risbourg, Bernadette Brennan, et al.
European Journal of Cancer (Oxford, England : 1990)|April 19, 2025
Corrigendum to "Association between local treatment modalities and event-free survival, overall survival, and local recurrence in patients with localised Ewing Sarcoma. Report from the Ewing 2008 trial" [Eur J Cancer 192 (2023) 113260]Philip Heesen, Andreas Ranft, Vivek Bhadri, et al.
Oncoimmunology|June 23, 2017
Ewing sarcoma partial regression without GvHD by chondromodulin-I/HLA-A*02:01-specific allorestricted T cell receptor transgenic T cellsUwe Thiel, Sebastian J Schober, Ingo Einspieler, et al.
Sarcoma|March 25, 2024
Factors Influencing the Outcome of Patients with Primary Ewing Sarcoma of the SacrumVictor Rechl, Andreas Ranft, Vivek Bhadri, et al.
Molecular Cancer|July 28, 2021
Translational evidence for RRM2 as a prognostic biomarker and therapeutic target in Ewing sarcomaShunya Ohmura, Aruna Marchetto, Martin F Orth, et al.
Pageof 9

Showing results (61-70 of 84) with videos related to

Sort By:
Pageof 9
European Journal of Cancer Care|June 23, 2020
Fertility education for adolescent cancer patients: Gaps in current clinical practice in EuropeElisabeth Korte, Ralph Schilling, Magdalena Balcerek, et al.
Advances in Radiation Oncology|June 19, 2023
Effect of Radiotherapy Dose on Outcome in Nonmetastatic Ewing SarcomaJosephine Kersting, Andreas Ranft, Vivek Bhadri, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|March 24, 2010
Impact of EWS-ETS fusion type on disease progression in Ewing's sarcoma/peripheral primitive neuroectodermal tumor: prospective results from the cooperative Euro-E.W.I.N.G. 99 trialMarie-Cecile Le Deley, Olivier Delattre, Karl-Ludwig Schaefer, et al.
European Journal of Cancer (Oxford, England : 1990)|August 18, 2023
Association between local treatment modalities and event-free survival, overall survival, and local recurrence in patients with localised Ewing Sarcoma. Report from the Ewing 2008 trialPhilip Heesen, Andreas Ranft, Vivek Bhadri, et al.
European Journal of Cancer (Oxford, England : 1990)|May 30, 2026
Treatment effect heterogeneity of radiotherapy in localized Ewing sarcoma: A secondary analysis of the EURO-E.W.I.N.G. 99 and Ewing 2008 trialPhilip Heesen, Stefan Feuerriegel, Olga Ciobanu-Caraus, et al.
European Journal of Cancer (Oxford, England : 1990)|July 20, 2024
Impact of age on safety of Busulfan-Melphalan followed by autologous hematopoietic stem-cell transplantation versus standard chemotherapy in the patients of the EURO-E.W.I.N.G. 99 and Ewing 2008 clinical trialsXavier Choderlos de Laclos, Séverine Risbourg, Bernadette Brennan, et al.
European Journal of Cancer (Oxford, England : 1990)|April 19, 2025
Corrigendum to "Association between local treatment modalities and event-free survival, overall survival, and local recurrence in patients with localised Ewing Sarcoma. Report from the Ewing 2008 trial" [Eur J Cancer 192 (2023) 113260]Philip Heesen, Andreas Ranft, Vivek Bhadri, et al.
Oncoimmunology|June 23, 2017
Ewing sarcoma partial regression without GvHD by chondromodulin-I/HLA-A*02:01-specific allorestricted T cell receptor transgenic T cellsUwe Thiel, Sebastian J Schober, Ingo Einspieler, et al.
Sarcoma|March 25, 2024
Factors Influencing the Outcome of Patients with Primary Ewing Sarcoma of the SacrumVictor Rechl, Andreas Ranft, Vivek Bhadri, et al.
Molecular Cancer|July 28, 2021
Translational evidence for RRM2 as a prognostic biomarker and therapeutic target in Ewing sarcomaShunya Ohmura, Aruna Marchetto, Martin F Orth, et al.
Pageof 9